ȯ Ǿǰ ߽ 1971 ǰ ƴ. 1978 ϸ鼭 ȯ߰, 2000 ڽڿ ߴ.
2006 ȭҷ ġ, ġ پ ǰ Ǹߴ. ȭҷ ġ Ǵ 7.36% ̾.
2007ʹ ȯ Ǿǰ ߽ ߴ. ǾƺƼ 'ö' () ũ 鼭ʹ. п ö Ǹž 1000 ܷ ǸŵǴ ó 2 ϰ ־.
ǰ ϴ Ѵ. ΰǸ 忡 Ȯ . ϸ ̾ ־ 忡 ȯڴ ؾ Ѵ. ù 2007 ũ 32% ߴ.
() ÷
2009 ũ þ鼭 ̾. ǰ Ÿ þ. 2006 Ƿ Ծ㰡, ǰɽǰ Ծ㰡 Ǹž㰡 δ. 2008 Ǿǰ Ż㰡 ޱ ߴ.
2010 . 2010 ũ 100 2009 45% ް ̴. 24.5% 11.6%P . 2010 2 ɳȯ, ʵƼ ȯ ġḦ 1 'ƽǸ' ϴ ȿ ̴.
迡 ȿ 3 Ҽ ̾. ڷῡ 2010 10 Ը 470 11% پ. ö 18% 74 ߴ. ö ǰ ũ δ.
2012 ٽ ݾ ȸƴ. ǰ մ ̴. 2011 9 ߱ ĸӼƼû(NEPTUNUS PHARMACEUTICAL COMPANY) ĵ ȯ ġῡ Ǵ ĸ ǰ ް üߴ.
2012 6 ʸ ߱ ġ , ġ øź ž δ. øź 'øź' ּ Ѵ. Ϻ 쿡 ϰ Ǹ ġ Ṱ 9 Ư㰡 ȣ, ž Ư㸦 ȸϰ ѹ ռ ־. øź ݾ 13 Ը ü 귮 20 ߴ.
ȭ Ǹ鼭 ġ 䰡 ð ִ øź Ǹſ ̴. 5 27 ΰǰܿ 2012 Ḧ ο 510 5Ⱓ 18% ߴ. ΰǰ ڷḦ ȯڴ 2015 800 Ѿ ̾ 2020Ⲳ 1200, 2020 1400 ȴ.
2007 ǰ 鼭 ߴ. Ư þµ ̴ δ. 2005 4.3%̴ ߺ 2007 9.7% . 2008 ٽ ߺ 5% 鼭 ͼ ȸƴ. ǰ 30% ϰ ִ.
1б ƴ. 91 2% þ. ƴ. 52% þ 10, 107% 10 ߴ. Ư ū Ÿ 94% ް ̴. Ư 1б ߴ ڻս 2 ʾҴ.
繫 췮, â ȣ
ä 20%~30% , 400% ̻ ߴ. Ϲ ä 100% ̸̰, 100% ̸̻ 繫 ٰ . âµ ȣϴ. Ȱ帧 (+) ϰ ִ.
..ų 100
κ װ ִ. 1б ݼڻ(ݹݼڻ + ܱڻ) 175, ü ڻ 24% ϰ ִ. ݰ ڻ Բ ϴ ִ.
2008 ڻ ڻ ߴ. 49̴ 164 þ. 2011 IFRS ԵǸ鼭 ڻ Ϻΰ ںε з ڻ ϰ, ںε ǥõƴ. 1б ںε 66̴.
ų ȸ. 2005 9 ִ 100 ؿԴ. ص ݾ Ѵٸ, ð 2.4%.
34 Ը ڻ ̴. 2009 ó ֱÿ 72 Ը ڻ ȴٰ , 3 ø ´. 10 ÿ ݾ 34 پ, 濹ڰ 9 ̷ٰ .
ÿ cGMP 뵵 . cGMP ȭ Ǿǰ ǰ, ̱ FDA cGMP GMP ϰ , Ǿǰ 㰡 cGMP ʼ 䱸ϰ ִ. ֱÿ μ 漼, 꼼 ־ ִ.
[VƮ 췮] , ž ÷
| VƮ(Value Chart) 췮ִ 繫м 'VƮ' 繫 췮 Ұϴ ڳԴϴ. VƮ ڿ ü 繫м 繫ǥ Ʈ м ֵ Դϴ.
( 0)